Healthequity Inc(NASDAQ:HQY) announced the earnings results for Fiscal Year 2017 and Q4. The results came in during After-Market on Mar 21, 2017. Based on the corporate Earnings and Guidance, many Investment Banking firms balance their portfolio to Sell and Buy Stocks based on their strategy of investing in stocks.Company reported revenue of $46.814M. Analysts estimated a revenue of $45.660M. The revenues were 2.53% above the estimates. Earnings per share were $0.07. The reported EPS was above estimates by 40%. Analysts had estimated an EPS of $0.05.
In a different note, Chardan Capital said it Initiates Coverage On Healthequity Inc, according to a research note issued on Feb 7, 2017. In the research note, the firm Announces the price-target to $47 per share. The shares have been rated ‘Buy’ by the firm. KeyBanc said it Initiates Coverage On Healthequity Inc, according to a research note issued on Jan 23, 2017. In the research note, the firm Announces the price-target to $60 per share. The shares have been rated ‘Overweight’ by the firm.
Healthequity Inc (HQY) shares turned negative on Fridays trading session with the shares closing down -2.15 points or -5.05% at a volume of 11,97,831. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $43.32. The peak price level was also seen at $43.32 while the days lowest was $40.01. Finally the shares closed at $40.4. The 52-week high of the shares is $49.25 while the 52-week low is $21.9. According to the latest information available, the market cap of the company is $2,405 M.
Several Insider Transactions has been reported to the SEC. On Mar 17, 2017, Stephen Neeleman (Founder and Vice Chairman) sold 40,169 shares at $45.85 per share price.Also, On Mar 3, 2017, Jon Kessler (President and CEO) sold 30,000 shares at $44.36 per share price.On Feb 22, 2017, Darcy G Mott (Executive VP and CFO) sold 10,000 shares at $42.60 per share price, according to the Form-4 filing with the securities and exchange commission.
HealthEquity Inc. is a provider of a range of solutions for managing health care accounts (Health Savings Accounts (HSAs)) Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. The Company’s platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings compare treatment options and pricing evaluate and pay healthcare bills receive personalized benefit and clinical information earn wellness incentives and make educated investment choices to grow their tax-advantaged healthcare savings. The Company’s products and services include healthcare saving and spending platform health savings accounts investment advisory services reimbursement arrangements and healthcare incentives.